The People Who Get Covid Twice

Prognosis: Misconception

Bloomberg

Health & Fitness, Science

4.1 • 838 Ratings

🗓️ 23 September 2020

⏱️ 16 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Scientists in Hong Kong reported last month what many had long suspected could happen. Someone who had recovered from Covid-19 caught the coronavirus again. Since then, about a dozen cases of re-infection have been reported worldwide. These cases demonstrate that a natural infection doesn’t lead to lasting protection, and that the pandemic could persist in the human population. Bloomberg News senior editor Jason Gale talked to health experts about what this means for our ability to stop the virus and to produce an effective immunization.

See omnystudio.com/listener for privacy information.

Transcript

Click on a timestamp to play from that location

0:00.0	What could you do if your data was working for you and not against you? With Bloomberg delivering
0:07.3	enterprise data directly to your systems, you get easy access to the details you want, optimized for
0:14.1	higher level analysis, and financial data experts committed to helping you maximize your every move.
0:24.0	Our data is made for more, so you can show the world what you're made of. Visit Bloomberg.com slash enterprise data to learn more.
0:33.6	Welcome to Prognosis. I'm Laura Carlson. It's day 196 since coronavirus was declared a global pandemic.
0:44.2	Today's main story, we're now learning that having had COVID-19 doesn't mean you can't get it again.
0:53.5	We'll discuss what that means for stopping the outbreak spread
0:57.3	and for the development of a vaccine.
1:01.5	But first, here's what happened in virus news today. What could you do if your data was working for you and not against you?
1:20.8	With Bloomberg delivering enterprise data directly to your systems, you get easy access to the details you want, optimized for higher level analysis, and financial data experts committed to helping you maximize your every move.
1:35.6	Our data is made for more, so you can show the world what you're made of.
1:41.1	Visit Bloomberg.com slash enterprise data to learn more.
1:48.5	COVID-19 could wipe out an estimated 500 million jobs globally. That's a bigger hit to the labor
1:57.3	market than economists anticipated, according to the international labor organization.
2:04.7	The ILO also predicts a much slower recovery at the end of this year.
2:11.5	The ILO said that global working hours were 17% lower than the end of 2019, equivalent to almost 500 million jobs.
2:23.2	That's up from 400 million projected in June.
2:30.1	Johnson & Johnson has begun dosing up to 60,000 volunteers in a study of its COVID-19 vaccine.
2:39.0	It's the first big U.S. trial of an inoculation that may only require one shot.
2:46.0	J&J is the fourth vaccine maker to move its candidate into late-stage human studies in the U.S.
2:54.9	If enrollment goes as expected, the trial could yield results as soon as the end of the year,
3:01.4	allowing the company to seek emergency authorization early next year if it proves effective.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Bloomberg, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Bloomberg and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.